Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

IBUPROFEN

6 approval events · latest 2026-07-22

AgencyFDA
Submission typeNDA
Latest action2026-07-22
Approval events6
BrandCHILDREN'S MOTRIN
SponsorKENVUE BRANDS
RouteORAL

Approval history

6 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.

DateAgencyTypeBrandSponsorRoute
2026-07-22FDANDACHILDREN'S MOTRINKENVUE BRANDSORAL
2026-06-26FDANDACHILDREN'S ADVIL-FLAVOREDHALEON US HOLDINGSORAL
2026-05-01FDANDACHILDREN'S ADVILHALEON US HOLDINGSORAL
2026-01-23FDANDACALDOLORAPOTEXINTRAVENOUS
2025-01-08FDANDAADVIL LIQUI-GELSHALEON US HOLDINGSORAL
2024-12-30FDANDAADVILHALEON US HOLDINGSORAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-30T00:28:04.967Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: approval:ibuprofen

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Same entity, elsewhere in the suite